The Oncosearch | Oncotarget

Combination of betulinic acid and chidamide synergistically inhibits Epstein-Barr virus replication through over-generation of reactive oxygen species Research Paper

Haibing Yu, Hongyu Zhang, Zhigang Chu, Qiongfang Ruan, Xueru Chen, Danli Kong, Xiaodong Huang, Huawen Li, Huanwen Tang, Hongjin Wu, Yifei Wang, Weiguo Xie, Yuanling Ding, Paul Yao

Published Jun 27, 2017 · Vol. 8, No. 37 · pp. 61646-61661

miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progression Research Paper

Michael R. Epis, Keith M. Giles, Dianne J. Beveridge, Kirsty L. Richardson, Patrick A. Candy, Lisa M. Stuart, Jacqueline Bentel, Ronald J. Cohen, Peter J. Leedman

Published Jun 27, 2017 · Vol. 8, No. 33 · pp. 55116-55134

Therapeutic efficacy of SYM004, a mixture of two anti-EGFR antibodies in human colorectal cancer with acquired resistance to cetuximab and MET activation Research Paper

Stefania Napolitano, Giulia Martini, Erika Martinelli, Valentina Belli, Alessia Parascandolo, Mikko O. Laukkanen, Vincenzo Sforza, Floriana Morgillo, Davide Ciardiello, Fortunato Ciardiello, Teresa Troiani

Published Jun 27, 2017 · Vol. 8, No. 40 · pp. 67592-67604

Up-regulation of CIT promotes the growth of colon cancer cells Research Paper

Zehua Wu, Xiangying Zhu, Wendi Xu, Yu Zhang, Lin Chen, Fabo Qiu, Binyuan Zhang, Liqun Wu, Zhihai Peng, Huamei Tang

Published Jun 27, 2017 · Vol. 8, No. 42 · pp. 71954-71964

Human CAFs promote lymphangiogenesis in ovarian cancer via the Hh-VEGF-C signaling axis Research Paper

Rui Wei, Mengqin Lv, Fei Li, Teng Cheng, Zhengzhong Zhang, Guiying Jiang, Yin Zhou, Ruiqiu Gao, Xiao Wei, Jicheng Lou, Xizi Wu, Danfeng Luo, Xiangyi Ma, Jin Jiang, Ding Ma, Ling Xi

Published Jun 27, 2017 · Vol. 8, No. 40 · pp. 67315-67328

Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway Research Paper

Jingwei Shao, Guirong Zheng, Hongning Chen, Jian Liu, Aixiao Xu, Fan Chen, Tao Li, Yusheng Lu, Jianguo Xu, Ning Zheng, Lee Jia

Published Jun 27, 2017 · Vol. 8, No. 45 · pp. 78351-78364

The antitumor effect of arsenic trioxide on hepatocellular carcinoma is enhanced by andrographolide Research Paper

Xuhua Duan, Tengfei Li, Xinwei Han, Jianzhuang Ren, Pengfei Chen, Hao Li, Shaojun Gong

Published Jun 27, 2017 · Vol. 8, No. 53 · pp. 90905-90915

Synergistic inhibition of colon cancer growth by the combination of methylglyoxal and silencing of glyoxalase I mediated by the STAT1 pathway Research Paper

Yuan Chen, Lei Fang, Gefei Li, Jiali Zhang, Changxi Li, Mengni Ma, Chen Guan, Fumao Bai, Jianxin Lyu, Qing H. Meng

Published Jun 22, 2017 · Vol. 8, No. 33 · pp. 54838-54857

5-Azacytidine promotes invadopodia formation and tumor metastasis through the upregulation of PI3K in ovarian cancer cells Research Paper

Dan Cao, Dan Li, Yong Huang, Yu Ma, Binglan Zhang, Chengjian Zhao, Senyi Deng, Min Luo, Tao Yin, Yu-Quan Wei, Wei Wang

Published Jun 20, 2017 · Vol. 8, No. 36 · pp. 60173-60187

Upregulation of CD11b and CD86 through LSD1 inhibition promotes myeloid differentiation and suppresses cell proliferation in human monocytic leukemia cells Research Paper

Jianwu Fang, Haiyan Ying, Ting Mao, Yanjia Fang, Yuan Lu, He Wang, Irene Zang, Zhaofu Wang, Ying Lin, Mengxi Zhao, Xiao Luo, Zongyao Wang, Yan Zhang, Chao Zhang, Wei Xiao, Yan Wang, Wei Tan, Zhui Chen, Chris Lu, Peter Atadja, En Li, Kehao Zhao, Jianfeng Liu, Justin Gu

Published Jun 19, 2017 · Vol. 8, No. 49 · pp. 85085-85101

Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma Research Paper

Narendra Bharathy, Matthew N. Svalina, Teagan P. Settelmeyer, Megan M. Cleary, Noah E. Berlow, Susan D. Airhart, Sunny Xiang, James Keck, James B. Hayden, Jack F. Shern, Atiya Mansoor, Melvin Lathara, Ganapati Srinivasa, David M. Langenau, Charles Keller

Published Jun 16, 2017 · Vol. 8, No. 38 · pp. 62976-62983

APIO-EE-9 is a novel Aurora A and B antagonist that suppresses esophageal cancer growth in a PDX mouse model Research Paper

Guoguo Jin, Ke Yao, Zhiping Guo, Zhenjiang Zhao, Kangdong Liu, Fangfang Liu, Hanyong Chen, Dhilli Rao Gorja, Kanamata Reddy, Ann M. Bode, Ziming Dong, Zigang Dong

Published Jun 16, 2017 · Vol. 8, No. 32 · pp. 53387-53404

Inhibition of FAK kinase activity preferentially targets cancer stem cells Research Paper

Vihren N. Kolev, Winnie F. Tam, Quentin G. Wright, Sean P. McDermott, Christian M. Vidal, Irina M. Shapiro, Qunli Xu, Max S. Wicha, Jonathan A. Pachter, David T. Weaver

Published Jun 16, 2017 · Vol. 8, No. 31 · pp. 51733-51747

20(S)-Rg3 blocked epithelial-mesenchymal transition through DNMT3A/miR-145/FSCN1 in ovarian cancer Research Paper

Jie Li, Jiaojiao Lu, Zhongxue Ye, Xi Han, Xia Zheng, Huilian Hou, Wei Chen, Xu Li, Le Zhao

Published Jun 15, 2017 · Vol. 8, No. 32 · pp. 53375-53386

Cryptotanshinone inhibits proliferation yet induces apoptosis by suppressing STAT3 signals in renal cell carcinoma Research Paper

Zhiguo Chen, Rujian Zhu, Jiayi Zheng, Chen Chen, Chi Huang, Junjie Ma, Chen Xu, Wei Zhai, Junhua Zheng

Published Jun 15, 2017 · Vol. 8, No. 30 · pp. 50023-50033

CFC1 is a cancer stemness-regulating factor in neuroblastoma Priority Research Paper

Koji Chikaraishi, Hisanori Takenobu, Ryuichi P. Sugino, Kyosuke Mukae, Jesmin Akter, Masayuki Haruta, Masafumi Kurosumi, Takaho A. Endo, Haruhiko Koseki, Naoki Shimojo, Miki Ohira, Takehiko Kamijo

Published Jun 13, 2017 · Vol. 8, No. 28 · pp. 45046-45059

Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer Research Paper

Jinyou Liu, Suryavathi Viswanadhapalli, Lauren Garcia, Mei Zhou, Binoj C. Nair, Edward Kost, Rajeshwar Rao Tekmal, Rong Li, Manjeet K. Rao, Tyler Curiel, Ratna K. Vadlamudi, Gangadhara R. Sareddy

Published Jun 12, 2017 · Vol. 8, No. 30 · pp. 50002-50014

Magnetic resonance imaging of RRx-001 pharmacodynamics in preclinical tumors Clinical Research Papers

Natarajan Raghunand, Jan Scicinski, Gerald P. Guntle, Bhumasamudram Jagadish, Eugene A. Mash, Elizabeth Bruckheimer, Bryan Oronsky, Ronald L. Korn

Published Jun 12, 2017 · Vol. 8, No. 60 · pp. 102511-102520

Biological specificity of CDK4/6 inhibitors: dose response relationship, in vivo signaling, and composite response signature Priority Research Paper

Erik S. Knudsen, Jack Hutcheson, Paris Vail, Agnieszka K. Witkiewicz

Published Jun 10, 2017 · Vol. 8, No. 27 · pp. 43678-43691

Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics Research Paper

Emanuela Gentile, Taro Oba, Jing Lin, Ruping Shao, Feng Meng, Xiaobo Cao, Heather Y. Lin, Majidi Mourad, Apar Pataer, Veerabhadran Baladandayuthapani, Dong Cai, Jack A. Roth, Lin Ji

Published Jun 9, 2017 · Vol. 8, No. 29 · pp. 48222-48239

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Combination of betulinic acid and chidamide synergistically inhibits Epstein-Barr virus replication through over-generation of reactive oxygen species Research Paper

miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progression Research Paper

Therapeutic efficacy of SYM004, a mixture of two anti-EGFR antibodies in human colorectal cancer with acquired resistance to cetuximab and MET activation Research Paper

Up-regulation of CIT promotes the growth of colon cancer cells Research Paper

Human CAFs promote lymphangiogenesis in ovarian cancer via the Hh-VEGF-C signaling axis Research Paper

Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway Research Paper

The antitumor effect of arsenic trioxide on hepatocellular carcinoma is enhanced by andrographolide Research Paper

Synergistic inhibition of colon cancer growth by the combination of methylglyoxal and silencing of glyoxalase I mediated by the STAT1 pathway Research Paper

5-Azacytidine promotes invadopodia formation and tumor metastasis through the upregulation of PI3K in ovarian cancer cells Research Paper

Upregulation of CD11b and CD86 through LSD1 inhibition promotes myeloid differentiation and suppresses cell proliferation in human monocytic leukemia cells Research Paper

Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma Research Paper

APIO-EE-9 is a novel Aurora A and B antagonist that suppresses esophageal cancer growth in a PDX mouse model Research Paper

Inhibition of FAK kinase activity preferentially targets cancer stem cells Research Paper

20(S)-Rg3 blocked epithelial-mesenchymal transition through DNMT3A/miR-145/FSCN1 in ovarian cancer Research Paper

Cryptotanshinone inhibits proliferation yet induces apoptosis by suppressing STAT3 signals in renal cell carcinoma Research Paper

CFC1 is a cancer stemness-regulating factor in neuroblastoma Priority Research Paper

Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer Research Paper

Magnetic resonance imaging of RRx-001 pharmacodynamics in preclinical tumors Clinical Research Papers

Biological specificity of CDK4/6 inhibitors: dose response relationship, in vivo signaling, and composite response signature Priority Research Paper

Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Combination of betulinic acid and chidamide synergistically inhibits Epstein-Barr virus replication through over-generation of reactive oxygen species Research Paper

miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progression Research Paper

Therapeutic efficacy of SYM004, a mixture of two anti-EGFR antibodies in human colorectal cancer with acquired resistance to cetuximab and MET activation Research Paper

Up-regulation of CIT promotes the growth of colon cancer cells Research Paper

Human CAFs promote lymphangiogenesis in ovarian cancer via the Hh-VEGF-C signaling axis Research Paper

Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway Research Paper

The antitumor effect of arsenic trioxide on hepatocellular carcinoma is enhanced by andrographolide Research Paper

Synergistic inhibition of colon cancer growth by the combination of methylglyoxal and silencing of glyoxalase I mediated by the STAT1 pathway Research Paper

5-Azacytidine promotes invadopodia formation and tumor metastasis through the upregulation of PI3K in ovarian cancer cells Research Paper

Upregulation of CD11b and CD86 through LSD1 inhibition promotes myeloid differentiation and suppresses cell proliferation in human monocytic leukemia cells Research Paper

Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma Research Paper

APIO-EE-9 is a novel Aurora A and B antagonist that suppresses esophageal cancer growth in a PDX mouse model Research Paper

Inhibition of FAK kinase activity preferentially targets cancer stem cells Research Paper

20(S)-Rg3 blocked epithelial-mesenchymal transition through DNMT3A/miR-145/FSCN1 in ovarian cancer Research Paper

Cryptotanshinone inhibits proliferation yet induces apoptosis by suppressing STAT3 signals in renal cell carcinoma Research Paper

CFC1 is a cancer stemness-regulating factor in neuroblastoma Priority Research Paper

Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer Research Paper

Magnetic resonance imaging of RRx-001 pharmacodynamics in preclinical tumors Clinical Research Papers

Biological specificity of CDK4/6 inhibitors: dose response relationship, in vivo signaling, and composite response signature Priority Research Paper

Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics Research Paper